Evidence map›Paper›PMID 28870093›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2017

Novel series of 1,2,4-trioxane derivatives as antimalarial agents.

Mithun Rudrapal, Dipak Chetia, Vineeta Singh

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 75 citations in OpenAlex.

  1. Identification of Metabolites and Antioxidant Constituents fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. UtilizingFrontiers in nutrition · 2023
    Article
  8. Identification of bioactive molecules fromJournal of King Saud University. Science · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Identification of bioactive compounds inJournal of advanced pharmaceutical technology & research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mithun Rudrapala Department of Pharmaceutical Sciences , Dibrugarh University , Dibrugarh , India.
Dipak Chetiaa Department of Pharmaceutical Sciences , Dibrugarh University , Dibrugarh , India.
Vineeta Singhb Parasite Bank, National Institute of Malaria Research (ICMR) , Sector 8 , Dwarka , New Delhi , India.
Dibrugarh University · INNational Institute of Malaria Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among three series of 1,2,4-trioxane derivatives, five compounds showed good in vitro antimalarial activity, three compounds of which exhibited better activity against P. falciparum resistant (RKL9) strain than the sensitive (3D7) one. Two best compounds were one from aryl series and the other from heteroaryl series with IC

Indexed as

AntimalarialsDose-Response Relationship, DrugHeterocyclic CompoundsMalariaMolecular Docking SimulationMolecular StructureParasitic Sensitivity TestsPlasmodium falciparumStructure-Activity Relationship1,2,4-trioxaneAntimalarialsHeterocyclic Compoundsantimalarialfalcipain 2 inhibitorsP. falciparumresistancetrioxane derivatives

Identifiers

PMID28870093
PMCPMC6009891
OpenAlexW2752012398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.